For Patients For Caregivers For Medical Professionals

HELPLINE 1-800-465-4837
Mon-Fri 9am – 5pm EST

Missouri State Resource Center

State Resources

Our Mission

ALF promotes education, advocacy, support services and research for the prevention, treatment and cure of liver disease. ALF Mid-America provides a wide variety of these services including information and referral, education programs, support groups, exciting fundraising events, and an array of volunteer opportunities.

Jacqueline Dominguez
National Senior Director, Engagement

For help with issues related to liver disease, please contact our Help Center by using the Live Chat feature at the bottom of your browser window or call us at (800) 465-4837 Monday through Friday 9 am to 5 pm Eastern Time or by email at info@liverfoundation.org.


Support groups provide a place for individuals affected by a similar condition or circumstance to provide and receive support and share their experiences.

Not all support groups are facilitated by a medical professional. Some support groups are facilitated by 3rd party organizations and individuals in this region.

ALF also has identified virtual online support groups you can take advantage of by visiting this page.


St. Louis

Pre & Post Liver Transplant Support Group

Barnes-Jewish Hospital
Center for Advanced Medicine Building
4921 Parkview Place
3rd Floor, Farrell Conference Room #2
St. Louis, MO 63110

Not an ALF-affiliated support group

Meets: Third Wednesday of each month, 6:30 – 8 PM
Phone: 314-747-9963

Kate Beermann, LCSW


Life with Primary Biliary Cholangitis

Join the PBC Support Group Facebook page for weekly discussions and presentations on different prominent topics in PBC!

Contact: Megan Glynn
Phone: 646-737-9402 | More Information

Click here to join the PBC Support Group facebook page to learn about PBC resouces, information, and gain community support!

The live discussions and chat sessions will occur every Wednesday from 9am-10am and 7pm-8pm. The information and discussions will remain posted for those who are unable to attend live!



Find a Clinical Trial anywhere…

Participating in a clinical trial is a great way to contribute to curing, preventing and treating liver disease and its complications. Start your search here to find clinical trials that need people like you.


NASH (Nonalcoholic Steatohepatitis)

Protocol
THIS TRIAL WILL BEGIN IN APRIL, 2021

Title
Phase 3 Semaglutide in NASH (ESSENCE)

Area
Liver

Indication
Current diagnosis of fatty liver disease with fibrosis

Treatment
Injectable medication for NASH

Notify
Malana Kanallakan
314- 328-6466


NASH (Nonalcoholic Steatohepatitis)

Protocol
THIS TRIAL IS CURRENTLY IN RECESS DUE TO COVID-19

Title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (AURORA)

Area
Liver

Indication
Current diagnosis of fatty liver disease with fibrosis

Treatment
Oral medication for NASH

Notify
Malana Kanallakan
314- 328-6466


NASH (Nonalcoholic Steatohepatitis)

Protocol
THIS TRIAL IS CURRENTLY IN RECESS DUE TO COVID-19

Title
A randomized, double-blind, parallel-group, multicenter study to assess efficacy, safety, and tolerability of oral tropifexor (LJN452) & licogliflozin (LIK066) combination therapy, compared to each monotherapy, for treatment of adult patients with nonalcoholic steatohepatitis (NASH) (ELIVATE)

Area
Liver

Indication
Current diagnosis of fatty liver disease with fibrosis

Treatment
Oral medication for NASH

Notify
Malana Kanallakan
314- 328-6466


Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD

University of Missouri Healthcare

The primary objective of the study is to evaluate safety and efficacy of ELAD with respect to overall survival of subjects with a clinical diagnosis of alcohol-induced liver decompensation (AILD) through at least Study Day 91.

Contact Susan Pew, RN Study Coordinator for more information.

Phone: 573-882-4758
Email: pews@health.missouri.edu


The Missouri Health Department has created an online tool for adding/updating information to the Missouri Viral Hepatitis Resource Directory. The goal is for the directory to provide a comprehensive list of all entities providing hepatitis related services.

To access the directory, click here.

Abukabr Adam, MD
SSM St. Mary’s Hospital

Maria Bernadette Doyle, MD
Washington University

Elizabeth Eliopoulos
SSM Health

Steve Fern, DO
Specialists in Gastroenterology

Jacqueline Fleckenstein, MD
Washington University

Brittney Gabris, RN, BSN
SSM Health

Eddie Island, MD
Saint Lukes

Ajay Jain, MD
SSM Cardinal Glennon Children’s Medical Center

Karen Johns, RN
SSM Health Saint Louis University Hospital

Adeel Khan, MD, MPH, FACS
Washington University

Sakil Kulkarni, MD
Washington University

Jennie Laflen, LMSW
SSM Health Saint Louis University Hospital

Kim Liss, MD
Washington University

Mustaffa Nassal, MD
Saint Louis University

Paul Ott, RDN, LD, CDE
Barnes-Jewish Hospital

Kamram Qureshi, MD
Saint Louis University

Lindsey Shinn, MSN, RN, CCRN-K
Saint Louis Children’s Hospital

Janis Stoll, MD
Saint Louis Children’s Hospital

Jeffrey Teckman, MD
Saint Louis University

Brent Tetri, MD
Saint Louis University

Heather Tille
SSM Health

Chintalapati Varma, MD
Saint Louis University

Chelsea Visintine, RDN, LD
Barnes-Jewish Hospital

Jenn Whitter, LMSW, MSW
Barnes-Jewish Hospital

In addition to the resources listed above in your state or district, ALF provides these resources that are available no matter where you are. Explore them now…


Share this page
FacebooktwitterlinkedinmailFacebooktwitterlinkedinmail
rssrss